$Editas Medicine (EDIT.US)$I really am tryna figure out if this is moving cause of insider buying and potential acquisition or just a pump group selling fomo
$Editas Medicine (EDIT.US)$ Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities Monday, 13th January at 9:00 am • Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel in vivo treatment for sickle cell disease and beta thalassemia • Achieved in vivo editing of liver cells in non-human primates and in vivo deliver...
1
Report
No comment yet
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Editas Medicine Stock Forum
Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities
Monday, 13th January at 9:00 am
• Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel in vivo treatment for sickle cell disease and beta thalassemia
• Achieved in vivo editing of liver cells in non-human primates and in vivo deliver...
No comment yet